BIOCRYST PHARMACEUTICALS INC short interest in 2020
In 2020, BIOCRYST PHARMACEUTICALS INC's disclosed short interest ran from 14.61% of shares outstanding on 15 Jan 2020 to 17.53% on 31 Dec 2020, a change of +2.92 percentage points. The year's high was 23.40% on 30 Oct 2020 and its low 9.69% on 28 Feb 2020, averaging 16.33% across 24 twice-monthly settlement dates. FINRA's days-to-cover figure peaked at 10.12 days on 30 Oct 2020. Full history: BIOCRYST PHARMACEUTICALS INC.
Cite this page
By year: 2018 · 2019 · 2020 · 2021 · 2022 · 2023 · 2024 · 2025 · 2026
2020 in figures
- Start of year
- 14.61% (15 Jan 2020)
- End of year
- 17.53% (31 Dec 2020)
- Change
- +2.92 pp
- High
- 23.40% (30 Oct 2020)
- Low
- 9.69% (28 Feb 2020)
- Average
- 16.33%
- Highest days to cover
- 10.12 (30 Oct 2020)
- SEC filings marked
- 8
Every report in 2020
| Settlement | Short interest | Days to cover | Filings since previous |
|---|---|---|---|
| 15 Jan 2020 | 14.61% | 7.53 | |
| 31 Jan 2020 | 10.41% | 3.05 | |
| 14 Feb 2020 | 9.92% | 6.45 | |
| 28 Feb 2020 | 9.69% | 2.78 | |
| 13 Mar 2020 | 10.41% | 1.56 | results (8-K), 10-K filed |
| 31 Mar 2020 | 10.29% | 2.74 | |
| 15 Apr 2020 | 11.43% | 2.06 | |
| 30 Apr 2020 | 11.60% | 1.19 | |
| 15 May 2020 | 11.07% | 1.24 | results (8-K), 10-Q filed |
| 29 May 2020 | 11.95% | 2.08 | |
| 15 Jun 2020 | 13.38% | 3.65 | |
| 30 Jun 2020 | 20.81% | 3.81 | |
| 15 Jul 2020 | 20.16% | 4.17 | |
| 31 Jul 2020 | 19.26% | 6.15 | |
| 14 Aug 2020 | 21.53% | 5.64 | results (8-K), 10-Q filed |
| 31 Aug 2020 | 19.00% | 8.79 | |
| 15 Sep 2020 | 19.62% | 6.63 | |
| 30 Sep 2020 | 20.61% | 8.00 | |
| 15 Oct 2020 | 21.58% | 9.88 | |
| 30 Oct 2020 | 23.40% | 10.12 | |
| 13 Nov 2020 | 21.56% | 8.76 | results (8-K), 10-Q filed |
| 30 Nov 2020 | 21.19% | 9.15 | |
| 15 Dec 2020 | 20.98% | 2.85 | |
| 31 Dec 2020 | 17.53% | 4.24 |
See also: BIOCRYST PHARMACEUTICALS INC's full history · most shorted US stocks of 2020 · today's US league.
About this data
US short interest data: FINRA (finra.org), shown as reported shares short divided by SEC-reported shares outstanding for each settlement date. FINRA® is a registered trademark of the Financial Industry Regulatory Authority, Inc. This site is not affiliated with or endorsed by FINRA or the SEC; displayed for personal reference, bulk redistribution is not permitted (see terms). Nothing here is investment advice. Method: methodology.